The medical device company said that the FDA had cleared its Catamaran SI Joint Fusion System for expanded use in augmenting thoracolumbar fusion.
Summary: Sentiment on Stocktwits improved to ‘extremely bullish’ from ‘bullish’ a day ago
The move could further increase Bitcoin's appeal at a time when cryptocurrencies are gaining favor among U.S. corporations and policymakers.
Canadian Solar CEO Shawn Qu acknowledged that near-to-mid-term uncertainties currently exist in the solar industry.
The drug showed no treatment benefit for patients in the study called REFOCUS-ALZ, the company said, while adding that the Alzheimer’s disease development program with Simufilam will be discontinued by the end of the second quarter of 2025.
Research and development expenses in the reported quarter rose by $2 million, primarily due to increased spending on the soquelitinib clinical trial for T-cell lymphoma.
According to a securities filing, Fertitta purchased 16,500 shares of Wynn on March 21 and March 24, with a price range of $80.99 to $84.93 per share, totaling approximately $1.38 million.
Lemonade achieved the IFP milestone in 8.5 years of selling its first policy, marking an approximate 150% compound annual growth rate.
Boeing plans to expand seeker production in 2025 and increase its growth in the years ahead to meet increasing defense and security needs globally.
While the buyback program could influence MOVE’s price and liquidity, it remains unclear how it directly reimburses affected users since Binance froze the proceeds “for the purpose of compensating users.”
